|
|
|
Volumn 23, Issue 3 SUPPL. 6, 1996, Pages 56-64
|
|
The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
ETOPOSIDE;
IFOSFAMIDE;
MITOLACTOL;
PLATINUM DERIVATIVE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SCREENING;
FEMALE;
HUMAN;
PRIORITY JOURNAL;
UTERINE CERVIX CARCINOMA;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CARCINOMA;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
IFOSFAMIDE;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0029944367
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (0)
|
